. "Na z\u00E1klad\u011B sou\u010Dasn\u00FDch poznatk\u016F bylo pro na\u0161i studii vybr\u00E1no n\u011Bkolik gen\u016F, jejich\u017E proteiny se pod\u00EDl\u00ED na mechanismu \u00FA\u010Dinku clopidogrelu a sestaven dostate\u010Dn\u011B velik\u00FD soubor vhodn\u00FDch pacient\u016F. Metodou DCE (denatura\u010Dn\u00ED kapil\u00E1rn\u00ED elektrofor\u00E9za) bylo vy\u0161et\u0159eno 294 jedinc\u016F s ischemickou chorobou srde\u010Dn\u00ED po perkut\u00E1nn\u00ED koron\u00E1rn\u00ED intervenc\u00ED s implantac\u00ED stenu pro SNP markery CYP2C2 (CYP2C2*2, CYP2C2*3), CYP2C19 (CYP2C19*2), ABCB1 (C3435T) a GpIIIa P1(A1/A2). Vzorky s nestandardn\u00EDm profilem byly n\u00E1sledn\u011B sekvenov\u00E1ny." . . . . . "6"^^ . "Molekul\u00E1rn\u00ED genetika protidesti\u010Dkov\u00E9 l\u00E9\u010Dby Clopidogrelem" . "5"^^ . . . . . "Molekul\u00E1rn\u00ED genetika protidesti\u010Dkov\u00E9 l\u00E9\u010Dby Clopidogrelem"@cs . "O, P(NS9988)" . "Bene\u0161ov\u00E1, Lucie" . . "Sekerka, Patrik" . "Based on current knowledge, was selected for our study, several genes whose protein is involved in the mechanism of action of clopidogrel and built a sufficiently large set of appropriate patients. DCE method (denaturing capillary electrophoresis) were examined 294 individuals with coronary heart disease for the SNP markers of CYP2C2 (CYP2C2 * 2, CYP2C2 * 3), CYP2C19 (CYP2C19 * 2), ABCB1 (C3435T) and P1 GpIIIa (A1/A2). Samples with non-standard profile were subsequently sequenced."@en . "RIV/26475821:_____/11:#0000080!RIV11-MZ0-26475821" . "Na z\u00E1klad\u011B sou\u010Dasn\u00FDch poznatk\u016F bylo pro na\u0161i studii vybr\u00E1no n\u011Bkolik gen\u016F, jejich\u017E proteiny se pod\u00EDl\u00ED na mechanismu \u00FA\u010Dinku clopidogrelu a sestaven dostate\u010Dn\u011B velik\u00FD soubor vhodn\u00FDch pacient\u016F. Metodou DCE (denatura\u010Dn\u00ED kapil\u00E1rn\u00ED elektrofor\u00E9za) bylo vy\u0161et\u0159eno 294 jedinc\u016F s ischemickou chorobou srde\u010Dn\u00ED po perkut\u00E1nn\u00ED koron\u00E1rn\u00ED intervenc\u00ED s implantac\u00ED stenu pro SNP markery CYP2C2 (CYP2C2*2, CYP2C2*3), CYP2C19 (CYP2C19*2), ABCB1 (C3435T) a GpIIIa P1(A1/A2). Vzorky s nestandardn\u00EDm profilem byly n\u00E1sledn\u011B sekvenov\u00E1ny."@cs . "213524" . . "Clopidogrel; resistence; polymorfismus"@en . "Min\u00E1rik, Marek" . . "Molekul\u00E1rn\u00ED genetika protidesti\u010Dkov\u00E9 l\u00E9\u010Dby Clopidogrelem"@cs . . . . "Kope\u010Dkov\u00E1, Marta" . . "Molecular genetics of clopidogrel antiplatelet therapy"@en . . . "[6E492C80CE38]" . "RIV/26475821:_____/11:#0000080" . "Molekul\u00E1rn\u00ED genetika protidesti\u010Dkov\u00E9 l\u00E9\u010Dby Clopidogrelem" . . . "M\u00E9sz\u00E1rosov\u00E1, Anna" . "Molecular genetics of clopidogrel antiplatelet therapy"@en . . .